Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Effect of CagriSema on body weight reduction and cardiometabolic risk factors in women by menopause status and hormone therapy use: A post hoc analysis of the REDEFINE 1 trial
Maria D. Hurtado Andrade1; Camila Martins Mazini Tavares2; Cynthia K. O. Contreras2; Anthony Fabricatore3; Emilia Huvinen4;Vandana Yadav5; Nanette F. Santoro6
MATERIALS AVAILABLE
Coming soon
18:15 - 19:15
PDT
Add to calendar
P-51
POSTER
Effect of CagriSema on body weight reduction and cardiometabolic risk factors in women: A post hoc analysis of the REDEFINE 1 trial
Maria D. Hurtado Andrade1; Camila Martins Mazini Tavares2; Cynthia K. O. Contreras2; Anthony Fabricatore3; Emilia Huvinen4;Vandana Yadav5; Nanette F. Santoro6